eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
10.45
+0.44 (4.40%)
At close: Apr 8, 2026, 4:00 PM EDT
10.31
-0.14 (-1.34%)
After-hours: Apr 8, 2026, 4:00 PM EDT

eXoZymes Statistics

Total Valuation

eXoZymes has a market cap or net worth of $88.61 million. The enterprise value is $85.62 million.

Market Cap88.61M
Enterprise Value 85.62M

Important Dates

The last earnings date was Tuesday, March 31, 2026, after market close.

Earnings Date Mar 31, 2026
Ex-Dividend Date n/a

Share Statistics

eXoZymes has 8.48 million shares outstanding. The number of shares has increased by 27.70% in one year.

Current Share Class 8.48M
Shares Outstanding 8.48M
Shares Change (YoY) +27.70%
Shares Change (QoQ) +0.07%
Owned by Insiders (%) 25.30%
Owned by Institutions (%) 47.13%
Float 6.33M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 24.77
P/TBV Ratio 25.73
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.37.

Current Ratio 2.51
Quick Ratio 2.27
Debt / Equity 0.37
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -132.56% and return on invested capital (ROIC) is -73.84%.

Return on Equity (ROE) -132.56%
Return on Assets (ROA) -63.90%
Return on Invested Capital (ROIC) -73.84%
Return on Capital Employed (ROCE) -220.60%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$295,443
Employee Count31
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -105,205
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -1.88% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -1.88%
50-Day Moving Average 8.78
200-Day Moving Average 11.38
Relative Strength Index (RSI) 76.50
Average Volume (20 Days) 4,816

Short Selling Information

The latest short interest is 9,642, so 0.11% of the outstanding shares have been sold short.

Short Interest 9,642
Short Previous Month 9,714
Short % of Shares Out 0.11%
Short % of Float 0.15%
Short Ratio (days to cover) 2.97

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -9.72M
Pretax Income -9.26M
Net Income -9.16M
EBITDA -9.43M
EBIT -9.72M
Earnings Per Share (EPS) -$1.09
Full Income Statement

Balance Sheet

The company has $3.04 million in cash and $1.24 million in debt, with a net cash position of $1.80 million or $0.21 per share.

Cash & Cash Equivalents 3.04M
Total Debt 1.24M
Net Cash 1.80M
Net Cash Per Share $0.21
Equity (Book Value) 3.40M
Book Value Per Share 0.40
Working Capital 2.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.50 million and capital expenditures -$169,917, giving a free cash flow of -$6.67 million.

Operating Cash Flow -6.50M
Capital Expenditures -169,917
Depreciation & Amortization 287,961
Net Borrowing -27,709
Free Cash Flow -6.67M
FCF Per Share -$0.79
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

eXoZymes does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -27.70%
Shareholder Yield -27.70%
Earnings Yield -10.48%
FCF Yield -7.63%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1